Preview

Current Pediatrics

Advanced search

Blueberry Muffin Baby Syndrome in a Patient with Congenital Leukemia: Clinical Case

https://doi.org/10.15690/vsp.v23i5.2793

Abstract

Background. Blueberry muffin baby syndrome in newborns is characterized by diffuse nodular skin lesions and it is difficult for diagnosis due to diverse etiology. Etiological factors include congenital infections, intrauterine hemolytic disease, multifocal vascular abnormalities, and neoplastic conditions. Congenital neonatal leukemia is rare disease and it is usually revealed during the first month of life. Clinical case description. This clinical case presents a patient with congenital acute myeloid leukemia and severe skin manifestations. Treatment has included risk-adapted chemotherapy with subsequent allogeneic hematopoietic stem cell transplantation from a haploidentical donor (father). Conclusion. The significance of multidisciplinary approach in management of patients with congenital leukemias consist of timely determination of the disease variant, prognostic risk group, and initiation of programmed treatment.

About the Authors

Timur Z. Aliev
National Medical Research Center of Oncology named after N.N. Blokhin
Russian Federation

Moscow


Disclosure of interest:

Other authors confirmed the absence of a reportable conflict of interests



Tatiana S. Belysheva
National Medical Research Center of Oncology named after N.N. Blokhin
Russian Federation

Moscow


Disclosure of interest:

Other authors confirmed the absence of a reportable conflict of interests



Elena B. Machneva
National Medical Research Center of Oncology named after N.N. Blokhin; Russian Children’s Clinical Hospital
Russian Federation

Moscow


Disclosure of interest:

Other authors confirmed the absence of a reportable conflict of interests



Timur T. Valiev
National Medical Research Center of Oncology named after N.N. Blokhin; Sechenov First Moscow State Medical University; Russian Medical Academy of Continuing Professional Education
Russian Federation

Moscow


Disclosure of interest:

Other authors confirmed the absence of a reportable conflict of interests



Natalia A. Batmanova
National Medical Research Center of Oncology named after N.N. Blokhin
Russian Federation

Moscow


Disclosure of interest:

Other authors confirmed the absence of a reportable conflict of interests



Irina O. Kostareva
National Medical Research Center of Oncology named after N.N. Blokhin
Russian Federation

Moscow


Disclosure of interest:

Other authors confirmed the absence of a reportable conflict of interests



Natalia A. Burlaka
National Medical Research Center of Oncology named after N.N. Blokhin
Russian Federation

Moscow


Disclosure of interest:

Other authors confirmed the absence of a reportable conflict of interests



Tatiana I. Potemkina
National Medical Research Center of Oncology named after N.N. Blokhin
Russian Federation

Moscow


Disclosure of interest:

Other authors confirmed the absence of a reportable conflict of interests



Karina A. Sergeenko
National Medical Research Center of Oncology named after N.N. Blokhin
Russian Federation

Moscow


Disclosure of interest:

Other authors confirmed the absence of a reportable conflict of interests



Lyudmila M. Kudaeva
Russian University of Medicine
Russian Federation

Moscow


Disclosure of interest:

Other authors confirmed the absence of a reportable conflict of interests



Irina Yu. Trushkova
National Medical Research Center of Oncology named after N.N. Blokhin
Russian Federation

Moscow


Disclosure of interest:

Other authors confirmed the absence of a reportable conflict of interests



Nikolay N. Murashkin
Sechenov First Moscow State Medical University; National Medical Research Center of Children’s Health; Central State Medical Academy of Department of Presidential Affairs
Russian Federation

Moscow


Disclosure of interest:

Nikolay N. Murashkin — receiving research grants from pharmaceutical companies Jansen, Eli Lilly, Novartis, AbbVie, Pfizer, Amryt Pharma plc. Receiving fees for scientific counseling from companies Galderma, L'Oreal, NAOS, Pierre Fabre, Bayer, LEO Pharma, Pfizer, Sanofi, Novartis, AbbVie, Glenmark, Janssen, Invar, Librederm, Viatris, JGL, B.Braun, Swixx BioPharma



Kirill I. Kirgizov
National Medical Research Center of Oncology named after N.N. Blokhin
Russian Federation

Moscow


Disclosure of interest:

Other authors confirmed the absence of a reportable conflict of interests



Svetlana R. Varfolomeeva
National Medical Research Center of Oncology named after N.N. Blokhin
Russian Federation

Moscow


Disclosure of interest:

Other authors confirmed the absence of a reportable conflict of interests



References

1. Chyżyñski B, Matysiak M. Blueberry muffin baby syndrome — review paper. Nowa Pediatria. 2019;23(1):34–39. doi: https://doi.org/10.25121/np.2019.23.1.34

2. Barnett HL, Einhorn AH. Paediatrics. 14th edn. New York: Appleton-Century-Crofts; 1968. p. 742.

3. Mehta V, Balachandran C, Lonikar V. Blueberry muffin baby: a pictoral differential diagnosis. Dermatol Online J. 2008;14(2):8.

4. Brodeur GM, Hogarty MD, Bagatell R, et al. Neuroblastoma. In: Principles and Practice of Pediatric Oncology. Pizzo PA, Poplack DG, eds. 7th edn. Philadelphia, PA: Wolters Kluwer; 2016. pp. 772–797.

5. Schwartz RA. Cutaneous metastatic disease. J Am Acad Dermatol. 1995;33(2 Pt 1):161–182; quiz 183–186. doi: https://doi.org/10.1016/0190-9622(95)90231-7

6. Darby JB, Valentine G, Hillier K, et al. A 3-Week-Old With an Isolated “Blueberry Muffin” Rash. Pediatrics. 2017;140(1):e20162598. doi: https://doi.org/10.1542/peds.2016-2598

7. Coenen EA, Zwaan CM, Reinhardt D, et al. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: A collaborative study by the International-Berlin-FrankfurtMünster AML-study group. Blood. 2013;122(15):2704–2713. doi: https://doi.org/10.1182/blood-2013-02-485524

8. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2010. Bethesda: National Cancer Institute, 2013.

9. Hafiz MG, Khaleque MA. Congenital Acute Lymphoblastic Leukemia: A Rare Presentation in a One Month Old Boy. Pediat Therapeut. 2014;(4):204. doi: https://doi.org/10.4172/2161-0665.1000204

10. Van der Linden MH, Creemers S, Pieters R. Diagnosis and management of neonatal leukaemia. Semin Fetal Neonatal Med. 2012; 17(4):192–195. doi: https://doi.org/10.1016/j.siny.2012.03.003

11. Resnik KS, Brod BB. Leukemia cutis in congenital leukemia. Analysis and review of the world literature with report of additional case. Arch Dermatol. 1993;129(10):1301–1306. doi: https://doi.org/10.1001/archderm.129.10.1301

12. Roberts I, Fordham NJ, Rao A, Bain BJ. Neonatal leukaemia. Br J Haematol. 2018;182(2):170–184. doi: https://doi.org/10.1111/bjh.15246

13. Maschan MA, Myakova NV. Acute lymphoblastic leukemia in children. Oncohematology. 2006;(1-2):50–63. (In Russ). doi: https://doi.org/10.17650/1818-8346-2006-0-1-2-50-63

14. Kislyak NS, Makhonova LA, Ivanovskaya TE. Klinicheskoe techenie ostrogo leikoza u detei. Moscow; 1972. 127 p. (In Russ).

15. Paina OV, Semenova EV, Markova IV, et al. Modern views on the treatment of acute leukemia in children under 1 year. Russian Journal of Pediatric Hematology and Oncology. 2019;6(2):11–19. (In Russ). doi: https://doi.org/10.21682/2311-1267-2019-6-2-11-19

16. Teixeira B, Losa A, Meireles A, et al. Blueberry Muffin Syndrome and Hyperleukocytosis in a Newborn: A Diagnostic Challenge. Cureus. 2024;16(1):e52869. doi: https://doi.org/10.7759/cureus.52869

17. Isaacs H Jr. Fetal and neonatal leukemia. J Pediatr Hematol Oncol. 2003;25(5):348–361. doi: https://doi.org/10.1097/00043426-200305000-00002

18. D’Orazio JA, Pulliam JF, Moscow JA. Spontaneous resolution of a single lesion of myeloid leukemia cutis in an infant: case report and discussion. Pediatr Hematol Oncol. 2008;25(5):457–468. doi: https://doi.org/10.1080/08880010802104494

19. Dinulos JG, Hawkins DS, Clark BS, et al. Spontaneous remission of congenital leukemia. J Pediatr. 1997;131(2):300–303. doi: https://doi.org/10.1016/s0022-3476(97)70170-7

20. van den Berg H, Hopman AH, Kraakman KC, et al. Spontaneous remission in congenital leukemia is not related to (mosaic) trisomy 21: case presentation and literature review. Pediatr Hematol Oncol. 2004;21(2):135–144. doi: https://doi.org/10.1080/08880010490273000

21. Bresters D, Reus ACW, Veerman AJP, et al. Congenital leukemia: the Dutch experience and review of the literature. Br J Haematol, 2002;117(3): 513–524. doi: https://doi.org/10.1046/j.1365-2141.2002.03459.x

22. Zhang IH, Zane LT, Braun BS, et al. Congenital leukemia cutis with subsequent development of leukemia. J Am Acad Dermatol. 2006;54(2 Suppl):S22–S27. doi: https://doi.org/10.1016/j.jaad.2005.04.038

23. Sotiriou E, Manousari A, Apalla Z, et al. Aleukaemic congenital leukaemia cutis: a critical primary sign of systemic disease. Acta Derm Venereol. 2011;91(2):203–204. doi: https://doi.org/10.2340/00015555-1005


Review

For citations:


Aliev T.Z., Belysheva T.S., Machneva E.B., Valiev T.T., Batmanova N.A., Kostareva I.O., Burlaka N.A., Potemkina T.I., Sergeenko K.A., Kudaeva L.M., Trushkova I.Yu., Murashkin N.N., Kirgizov K.I., Varfolomeeva S.R. Blueberry Muffin Baby Syndrome in a Patient with Congenital Leukemia: Clinical Case. Current Pediatrics. 2024;23(5):350-355. (In Russ.) https://doi.org/10.15690/vsp.v23i5.2793

Views: 436


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)